A Comparative Study Between Laryseal Pro Extraglottic Device and Ambu Aura Gain Laryngeal Mask as a Conduit for Fiberoptic Tracheal Intubation in Pediatric Population

Recruiting now · Not applicable

Conditions studied: Laryseal Pro and Ambu Aura Gain as Conduits for Fiberoptic Endotracheal Intubation

In brief

This study aims to compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric population.

Key facts

Study ID

NCT06945029

Run by

Cairo University

People needed

100

Starts

2025-04-15

Expected to finish

2026-04-01

Last updated by the study team

2025-04-25

Who can join

Age: 4 and older, up to 8. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age starting from 4 years to 8 years.
• Both genders.
• ASA physical status class I-ll.
• Apparently anatomically normal with normal percentile growth chart, not suspected to have difficult airway.
• Scheduled for day case surgeries more than one hour under general anesthesia.

You may not qualify if…

• Parents refusal.
• Abnormality in head and neck or craniofacial anomalies as Piere Robbin syndrome, facial trauma, head and neck tumours, swellings and hemangiomas.
• Patients at risk of regurgitation and pulmonary aspiration such as patients with hiatus hernia, GERD or DM.
• Abnormal or contraindicated cervical spine flexion/extension/rotation.
• Allergy to any EAD components.
• Any active respiratory or cardiac disease and metabolic disorders.

Where it is running

• Faculty of Medicine, Cairo University — Cairo, Giza Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.